Mark A. Suckow

5.6k total citations
140 papers, 4.2k citations indexed

About

Mark A. Suckow is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Mark A. Suckow has authored 140 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 25 papers in Surgery and 22 papers in Immunology. Recurrent topics in Mark A. Suckow's work include Protease and Inhibitor Mechanisms (14 papers), Immunotherapy and Immune Responses (13 papers) and RNA Interference and Gene Delivery (12 papers). Mark A. Suckow is often cited by papers focused on Protease and Inhibitor Mechanisms (14 papers), Immunotherapy and Immune Responses (13 papers) and RNA Interference and Gene Delivery (12 papers). Mark A. Suckow collaborates with scholars based in United States, India and Australia. Mark A. Suckow's co-authors include William R. Wolter, Valerie A. Schroeder, Mayland Chang, Shahriar Mobashery, Major Gooyit, Bradley D. Smith, Peggy J. Danneman, Cory Brayton, William Wolter and Terry L. Bowersock and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

Mark A. Suckow

138 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Suckow United States 34 1.4k 451 440 416 380 140 4.2k
Monika Schäfer‐Korting Germany 49 2.2k 1.6× 668 1.5× 473 1.1× 180 0.4× 142 0.4× 180 7.8k
Chun‐Ming Huang United States 43 2.9k 2.0× 944 2.1× 241 0.5× 1.3k 3.1× 277 0.7× 157 7.7k
Margit Mahlapuu Sweden 34 3.8k 2.7× 548 1.2× 380 0.9× 247 0.6× 311 0.8× 72 5.8k
Wojciech Kamysz Poland 42 2.7k 1.9× 566 1.3× 608 1.4× 230 0.6× 225 0.6× 225 5.8k
Richard White United Kingdom 45 2.7k 1.9× 193 0.4× 905 2.1× 603 1.4× 352 0.9× 189 6.6k
Stanley A. Schwartz United States 44 2.0k 1.5× 1.7k 3.7× 205 0.5× 549 1.3× 378 1.0× 196 6.9k
Valbert Nascimento Cardoso Brazil 39 1.8k 1.3× 257 0.6× 197 0.4× 543 1.3× 147 0.4× 227 5.0k
Ehrhardt Proksch Germany 47 1.4k 1.0× 873 1.9× 148 0.3× 212 0.5× 170 0.4× 112 7.4k
Randall J. Mrsny United States 45 3.1k 2.2× 714 1.6× 140 0.3× 687 1.7× 280 0.7× 123 6.8k
Ling‐juan Zhang China 31 1.3k 0.9× 964 2.1× 425 1.0× 189 0.5× 156 0.4× 70 3.8k

Countries citing papers authored by Mark A. Suckow

Since Specialization
Citations

This map shows the geographic impact of Mark A. Suckow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Suckow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Suckow more than expected).

Fields of papers citing papers by Mark A. Suckow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Suckow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Suckow. The network helps show where Mark A. Suckow may publish in the future.

Co-authorship network of co-authors of Mark A. Suckow

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Suckow. A scholar is included among the top collaborators of Mark A. Suckow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Suckow. Mark A. Suckow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suckow, Mark A., et al.. (2025). Autologous Cancer Vaccines: A Precision Immunotherapy Strategy for Veterinary Cancer Patients. Anticancer Research. 45(10). 4115–4130.
2.
Suckow, Mark A. & Marie Fallon. (2024). The ARRIVE 2.0 Guidelines: Importance and Full Adoption by AALAS Journals. Journal of the American Association for Laboratory Animal Science. 63(5). 449–454.
3.
Suckow, Mark A., et al.. (2022). Field Safety Experience With an Autologous Cancer Vaccine in 41 Horses: A Retrospective Study (2019–2021). Journal of Equine Veterinary Science. 114. 103948–103948. 3 indexed citations
4.
Nguyen, Trung T., Derong Ding, William R. Wolter, et al.. (2018). Expression of active matrix metalloproteinase-9 as a likely contributor to the clinical failure of aclerastide in treatment of diabetic foot ulcers. European Journal of Pharmacology. 834. 77–83. 19 indexed citations
5.
Suckow, Mark A., et al.. (2017). Use of a Rat Model to Study Ventral Abdominal Hernia Repair. Journal of Visualized Experiments. 3 indexed citations
6.
Suckow, Mark A., William R. Wolter, & Giles E. Duffield. (2017). The Impact of Environmental Light Intensity on Experimental Tumor Growth. Anticancer Research. 37(9). 4967–4971. 3 indexed citations
7.
Ashley, Jonathan D., et al.. (2016). Dual Carfilzomib and Doxorubicin–Loaded Liposomal Nanoparticles for Synergistic Efficacy in Multiple Myeloma. Molecular Cancer Therapeutics. 15(7). 1452–1459. 55 indexed citations
8.
Bouley, Renee A., Malika Kumarasiri, Zhihong Peng, et al.. (2015). Discovery of Antibiotic ( E )-3-(3-Carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3 H )-one. Journal of the American Chemical Society. 137(5). 1738–1741. 119 indexed citations
9.
Semple, Bridgette D., Linda J. Noble‐Haeusslein, Major Gooyit, et al.. (2015). Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse. PLoS ONE. 10(11). e0143386–e0143386. 15 indexed citations
10.
Gooyit, Major, Shanyan Chen, Jennifer M. Walker, et al.. (2013). Selective Inhibition of Matrix Metalloproteinase-9 Attenuates Secondary Damage Resulting from Severe Traumatic Brain Injury. PLoS ONE. 8(10). e76904–e76904. 96 indexed citations
11.
Muralidharan-Chari, Vandhana, Holly Hoover, James Clancy, et al.. (2009). ADP-Ribosylation Factor 6 Regulates Tumorigenic and Invasive Properties In vivo. Cancer Research. 69(6). 2201–2209. 85 indexed citations
12.
Suckow, Mark A., Linda S. Gutierrez, William R. Wolter, et al.. (2004). The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice. Cancer Letters. 209(2). 165–169. 8 indexed citations
13.
Hodde, Jason P., Mark A. Suckow, William R. Wolter, & Michael C. Hiles. (2004). Small intestinal submucosa does not promote PAIII tumor growth in Lobund-Wistar rats. Journal of Surgical Research. 120(2). 189–194. 11 indexed citations
14.
Rosen, Elliot D., et al.. (2003). In utero transplantation of wild-type fetal liver cells rescues factor X-deficient mice from fatal neonatal bleeding diatheses. Journal of Thrombosis and Haemostasis. 1(1). 19–27. 16 indexed citations
15.
Suckow, Mark A., et al.. (2002). Sebaceous Adenocarcinoma of the External Auditory Canal in a New Zealand White Rabbit. Journal of Comparative Pathology. 127(4). 301–303. 13 indexed citations
16.
Suckow, Mark A., Kinam Park, L. Siger, et al.. (2000). Immunogenicity of antigens in boiled alginate microspheres. Journal of Biomaterials Science Polymer Edition. 11(1). 55–68. 4 indexed citations
17.
Suckow, Mark A., et al.. (1999). Enhanced Bone Regeneration Using Porcine Small Intestinal Submucosa. Journal of Investigative Surgery. 12(5). 277–287. 70 indexed citations
18.
Suckow, Mark A., et al.. (1996). Evaluation of the Analgesic Effects of Butorphanol Tartrate, Xylazine Hydrochloride, and Flunixin Meglumine in Leopard Frogs (Rana pipiens). 35(3). 54–56. 12 indexed citations
19.
Bowersock, Terry L., et al.. (1994). Oral vaccination of animals via hydrogels. 79–80. 1 indexed citations
20.
Keren, David F. & Mark A. Suckow. (1994). [11] Animal models for immunoglobulin a secretion. Methods in enzymology on CD-ROM/Methods in enzymology. 235. 140–155. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monika Schäfer‐Korting Breakdown of academic impact, for papers by Chun‐Ming Huang Breakdown of academic impact, for papers by Margit Mahlapuu Breakdown of academic impact, for papers by Wojciech Kamysz Breakdown of academic impact, for papers by Richard White Breakdown of academic impact, for papers by Stanley A. Schwartz Breakdown of academic impact, for papers by Valbert Nascimento Cardoso Breakdown of academic impact, for papers by Ehrhardt Proksch Breakdown of academic impact, for papers by Randall J. Mrsny Breakdown of academic impact, for papers by Ling‐juan Zhang
Rankless by CCL
2026